SeqOne is thrilled to join clinicians, researchers, and biotech leaders to advance precision healthcare at SFMPP 2026, organized by the French Society of Personalised and Precision Medicine. 

The meeting focuses on translating multi-omics innovations, targeted therapies, and genomic insights into routine clinical practice across oncology and rare diseases.

Key Themes: 

  • Multi-Omics & Biomarkers: Integrating genomics, transcriptomics, and novel biomarkers into routine diagnostic and therapeutic decision-making.
  • Therapeutic Innovation & Oncology: Exploring targeted therapies, resistance mechanisms, and personalized treatment strategies in precision oncology.
  • Implementation & Health Economics: Navigating regulatory frameworks, reimbursement models, and equitable access for clinical precision medicine.
  • Data Science & AI in Care: Leveraging bioinformatic pipelines and artificial intelligence to refine variant interpretation and clinical reporting.

‍

🧬 Experience the platform at SFMPP 2026

  • One NGS Platform, Built for Scale: End-to-end interpretation workflow with broad wet lab and sequencer compatibility.
  • AI Precision for Clinical Workflows: Built for real-world labs, SeqOne delivers fast, actionable insights, helping your team spend less time on variant interpretation and more time on confident clinical decisions.
  • Evaluate SeqOne for yourself: Visit our booth to explore our latest resources and learn how to start a free 30-day trial using your own data.

‍

👋 Meet the SeqOne Team

In town for the event? Let's connect! We’re booking 1-on-1 sessions to discuss whatever is top of mind for your team, from scientific collaborations and business inquiries to live walkthroughs of our NGS platform.

‍

Martin Dubuc
CEO

‍

Nicolas Philippe
President, Founder, & CSO

‍

Christophe Meynier
VP Global Sales

‍

Laëtitia Hazan
Field Application Scientist

‍